GnRH agonist therapy and the use of sex steroid add-back: improving the product

In: Expert Review of Obstetrics & Gynecology · 2011 · vol. 6(6) , pp. 583–585 · doi:10.1586/eog.11.58 · W2156744206
article OA: closed CC0
View on OpenAlex View at publisher
AI-generated summary by gemini-2.5-flash-lite, 2026-06-07

This review discusses GnRH agonist therapy and sex steroid add-back as a treatment for endometriosis-associated pain, aiming to improve efficacy and patient outcomes.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Medical therapy for the treatment of endometriosis-associated pain is a common approach used by clinicians worldwide. The field has been dominated by hormonal agents that modify the endocriologic m...

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (10)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
unpaywall
last seen: 2026-09-20T06:29:17.529187+00:00
License: CC0 · commercial use OK